الولايات المتحدة · منصات وبيانات · MarketBeat

Rhythm Pharmaceuticals (NASDAQ:RYTM) Stock Price Target Cut by Needham & Company LLC

نشره MarketBeat · الولايات المتحدة منذ 1 س

Needham & Company LLC lowered their price target on Rhythm Pharmaceuticals from $130.00 to $114.00 and set a "buy" rating on the stock in a report on Tuesday.

اقرأ المقال كاملًا على MarketBeat سجّل الدخول للحفظ

يعرض MarketNews العنوان والملخص كما نشرتهما الوسيلة الإعلامية. المقال الكامل متوفر على موقع الناشر. (www.marketbeat.com)

يستحق القراءة أيضًا

Seeking Alpha

USANA Health Sciences Non-GAAP EPS of -$0.11 misses by $0.22, revenue of $205.89M misses by $11.53M

The Motley Fool

Douglas Dynamics (PLOW) Q3 2026 Earnings Call Transcript

MarketWatch

S&P 500 is looking over the edge of a technical cliff — what happens if it falls off?

Investing.com

Postal Realty earnings missed by $0.01, revenue topped estimates

CNBC

Stock market after midterm elections: What S&P 500 history shows

Benzinga